The document discusses the role of stem cells in treating infertility, defining infertility primarily as the inability to conceive after one year of unprotected intercourse. It highlights that while significant advancements have been made in assisted reproduction, the use of stem cells for creating new egg cells remains uncertain, with current research focusing on existing eggs in women. Stemgenn Therapeutics is presented as a leading company offering stem cell therapies and consulting services for infertility and other health issues.
Related topics: